Viridian Therapeutics Inc... (VRDN)

AI Score

Unlock

11.82

-0.83 (-6.56%)

At close: Apr 04, 2025, 10:53 AM

Viridian Therapeutics Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	99.59M	102.83M	155.58M	42.3M	45.9M	24.85M	32.61M	47.44M	3.34M	10.83M	5.12M	209.35K	112.53K
Short-Term Investments	617.99M	374.54M	268.97M	154.67M	81.74M	2M	29.88M	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	501K	604K	7.61M	1.49M	857K	-523K	50K	50K	258K	15K	90K	690.05K	45.58K
Receivables	n/a	102K	102K	451K	n/a	108K	24K	1.46M	524K	394K	1.09M	994.01K	1.2M
Inventory	n/a	n/a	-6.62M	n/a	n/a	n/a	n/a	1.00	64K	187K	179K	356.64K	169.54K
Other Current Assets	20.88M	9.01M	6.52M	n/a	n/a	2.79M	2.87M	2.97M	170K	321K	n/a	50K	56.21K
Total Current Assets	738.46M	486.48M	424.55M	200.16M	129.61M	29.74M	65.37M	51.87M	4.26M	11.73M	6.79M	2.05M	1.66M
Property-Plant & Equipment	3.44M	3.34M	2.94M	2.06M	787K	523K	727K	563K	625K	1.15M	1.21M	928.03K	1.07M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.94M	3.95M	10.54M	3.55M	1.64M	523K	777K	613K	883K	1.17M	1.3M	1.62M	1.12M
Total Assets	742.4M	490.42M	435.09M	203.71M	131.25M	30.26M	66.15M	52.48M	4.26M	12.9M	8.09M	3.67M	2.78M
Account Payables	2.14M	2.24M	14.23M	2.33M	670K	1.1M	571K	906K	159K	242K	255K	100K	26.66K
Deferred Revenue	288K	288K	288K	289K	301K	5.01M	3.79M	n/a	3.38M	1.02M	n/a	76.41K	788.19K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	3.98M	2.29M	n/a	n/a	1.1M	80K	697.06K	22.59M
Other Current Liabilities	44.93M	12.75M	4.87M	6.85M	7.29M	1.68M	239K	353K	1.17M	295K	1.4M	194.31K	200K
Total Current Liabilities	47.87M	26.64M	33.35M	13.64M	10.67M	10.18M	6.73M	3.9M	4.58M	2.47M	1.99M	1.39M	23.6M
Long-Term Debt	20.58M	20.2M	4.64M	n/a	n/a	4.33M	8M	9.92M	2.82M	n/a	n/a	n/a	42.05K
Other Long-Term Liabilities	2.02M	989K	1.17M	1.21M	544K	n/a	66K	152K	n/a	24K	109K	259.35K	578.8K
Total Long-Term Liabilities	22.89M	21.77M	6.68M	2.36M	544K	4.33M	8.07M	10.07M	2.82M	24K	109K	259.35K	620.85K
Total Liabilities	70.76M	48.4M	40.03M	15.99M	11.22M	14.51M	14.8M	13.97M	4.58M	2.49M	2.1M	1.65M	24.22M
Total Debt	21.09M	21.05M	5.26M	520K	455K	8.3M	10.3M	9.92M	1.04M	1.1M	80K	697.06K	22.63M
Common Stock	810K	540K	414K	239K	42K	349K	308K	226K	7K	106K	38K	27.91K	n/a
Retained Earnings	-995.86M	-725.91M	-488.17M	-358.3M	-278.89M	-168.17M	-126.3M	-93.59M	-30.64M	-17.97M	-6.64M	-25.89M	-21.44M
Comprehensive Income	-10K	338K	-390K	-157K	-8K	n/a	-3K	-2.83M	-0.00	-739K	-555K	-411.05K	-262.74K
Shareholders Equity	671.64M	442.02M	395.06M	187.72M	120.04M	15.75M	51.34M	38.51M	-326K	10.41M	5.99M	2.03M	-21.44M
Total Investments	617.99M	374.54M	268.97M	154.67M	81.74M	2M	29.88M	n/a	n/a	n/a	n/a	n/a	n/a